International Isotopes Stock News

Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the prior year Theranostics Sales increased 42% compared the Third Quarter in the prior year The Company report

Theranostics Sales increased 25% in the Second Quarter, and 16% for the Six Months Ended June 30, 2024 Gross Profit improved to 64%, a 7% increase, for the Six Months Ended June 30, 2024 Net Cash Prov

Theranostics Products Revenues Increased 8% in the Three Months Ended March 31, 2024; Net Cash Provided By Operating Activities Was Approximately $400,000 in the Three Months Ended March 31, 2024; Gro

Revenues Increased 10% in the Twelve Months Ended December 31, 2023 versus prior year Revenue of $12.3 million in the Twelve Months Ended December 31, 2023 was the highest in Company history Gross Pro

IDAHO FALLS, Idaho , Feb. 8, 2024 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it has entered into a defin

Revenues Increased 14% in the Nine Months Ended September 30, 2023; Operating Loss Improved 43% in the Nine Months Ended September 30, 2023; and Gross Profit Increased 19% Nine Months Ended September

Revenues Increased 28% in the Second Quarter; Net Cash Generation from Operations of more than $1,000,000 For The Six Months Ended June 30, 2023; June 30 th Cash Balance Remains In Excess Of $3,000,00

Long Time Chief Executive Officer Steve Laflin Announced He Will Be Stepping Down September 1, 2023; Shahe Bagerdjian Appointed as CEO IDAHO FALLS, Idaho , July 18, 2023 /PRNewswire/ -- International

International Isotopes (OTCMKTS: INIS) is one of 26 publicly-traded companies in the Process control instruments industry, but how does it compare to its peers? We will compare International Isotopes to related businesses based on the strength of its analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Earnings & Valuation This table compares International []

International Isotopes (OTCMKTS: INIS) is one of 26 publicly-traded companies in the Process control instruments industry, but how does it compare to its peers? We will compare International Isotopes to related companies based on the strength of its institutional ownership, profitability, risk, valuation, analyst recommendations, earnings and dividends. Analyst Ratings This is a summary of []

IDAHO FALLS, Idaho, Dec. 7, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") is pleased to announce updated information regarding research it has been funding towards an advanced disease testing procedure for SARS CoV-2, the virus

International Isotopes (OTCMKTS: INIS) is one of 26 public companies in the Process control instruments industry, but how does it contrast to its peers? We will compare International Isotopes to similar businesses based on the strength of its risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Earnings and Valuation This table compares International []

International Isotopes (OTCMKTS: INIS) is one of 26 public companies in the Process control instruments industry, but how does it contrast to its peers? We will compare International Isotopes to similar businesses based on the strength of its dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Analyst Ratings This is a summary of []

International Isotopes (OTCMKTS: INIS) is one of 26 publicly-traded companies in the Process control instruments industry, but how does it weigh in compared to its competitors? We will compare International Isotopes to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Institutional and Insider Ownership 66.3% []

International Isotopes (OTCMKTS: INIS) is one of 26 public companies in the Process control instruments industry, but how does it weigh in compared to its rivals? We will compare International Isotopes to related companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends. Analyst Ratings This is a []